ArticleInflammation2026
A Novel Insight into Chronic Pancreatitis Pathogenesis: the USP1/ITGB5 Axis-Mediated Stellate Cell Activation.
Article in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- LPA1-Induced EMT of Retinal Pigment Epithelial Cells Promotes Subretinal Fibrosis via USP1-Mediated Deubiquitination and Stabilization of ZEB1.Investigative ophthalmology & visual science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Chronic pancreatitis (CP) is characterized by chronic pancreatic inflammation and progressive fibrosis. This study investigated the role of ubiquitin-specific peptidase 1 (USP1), a protein-stabilizing deubiquitinase, in CP. C57BL/6J mice were given 8-week repetitive intraperitoneal cerulein (50 µg/kg) injections to establish the CP model. USP1 expression in CP mouse pancreatic tissues was 3-fold higher than in controls. Lentivirus-mediated Usp1 knockdown reduced pancreatic inflammatory cell infiltration, trypsin activity, and proinflammatory cytokine levels. Additionally, Usp1 knockdown inhibits collagen deposition and fibrosis of the pancreas. In vitro, USP1 was upregulated in activated pancreatic stellate cells (PSCs) induced by TGF-β1 (5 ng/mL). USP1 knockdown decreased the expressions of collagen type I alpha 1 chain (COL1A1), COL1A2, fibronectin, and α-smooth muscle actin (α-SMA), suppressing PSC activation and extracellular matrix production. Immunoprecipitation-liquid chromatography/mass spectrometry (IP-LC/MS) and label-free proteomics identified integrin subunit beta 5 (ITGB5) as a potential target protein of USP1. USP1 promoted ITGB5 deubiquitination/stabilization, while USP1 knockdown reduced ITGB5 expression. Rescue experiments showed ITGB5 overexpression reversed the inhibitory effect of USP1 knockdown on PSC activation. Moreover, ITGB5 knockdown inhibited PSC activation via suppressing PI3K/AKT pathway. In conclusion, USP1 knockdown inhibits PSC activation by suppressing the ITGB5-PI3K-AKT axis, thereby alleviating the pathological progression of CP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.